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Background:  In patients with severe aortic stenosis undergoing surgical aortic valve replacement, left ventricular (LV) dysfunction and low 
mean aortic valve gradient (AVG) are associated with an increased risk of poor outcomes. Similar associations have been suggested for 
patients undergoing transcatheter aortic valve replacement (TAVR), but these studies have been small with limited ability to adjust for other 
prognostically important covariates.
methods:  Using data from 5514 patients included in the TVT registry, we compared baseline characteristics and in-hospital and 1 year 
clinical outcomes among patients with varying degrees of LV dysfunction (LVEF < 30%; LVEF 30-50%; LVEF > 50%) and low and high AVG 
(AVG < 40mmHg; AVG > 40mmHg). We used multivariable hierarchical logistic regression and proportional hazards models to estimate the 
effect of AVG and LVEF on outcomes while adjusting for 19 baseline covariates. Effect modification between LV function and AVG was also 
examined using interaction terms.
results:  As expected, baseline characteristics differed significantly according to both LVEF and AVG. After risk adjustment, severe LV 
dysfunction (LVEF < 30%) was associated with increased in-hospital mortality (OR 1.56, 95% CI 1.01-2.42; p = 0.047) but not 1-year 
mortality (HR 1.15, 95% CI 0.91 - 1.45, p = 0.25). In contrast, low AVG (mean 30 + 7 mmHg vs. 53 + 12 mmHg in high AVG cohort) at 
baseline was independently associated with increased 1-year mortality (adjusted HR 1.28, 95% CI 1.13-1.46; p < 0.001), although no 
difference was seen in in-hospital mortality. There was no evidence of significant interaction between LVEF and AVG at discharge or at 1 
year.
conclusion:  Based on more than 5000 “real world” patients undergoing TAVR, low AVG, but not severe LV dysfunction, was 
independently associated with reduced survival at 1 year These data suggest that LV dysfunction, per se, should not preclude treatment 
with TAVR_particularly when associated with a high aortic valve gradient. Further analyses investigating the relationship between these 
factors and both functional status and cardiac re-hospitalization will be available for presentation in 3/15.
